Lv0
0 积分 2024-04-18 加入
PL02.12 Ivonescimab vs Placebo Plus Chemo, Phase 3 in Patients with EGFR+ NSCLC Progressed with 3rd gen EGFR-TKI Treatment: HARMONi
1天前
待确认
MA10.03 Efficacy and Safety of Cadonilimab Plus Pulocimab in NSCLC Patients Who Progressed Following Prior Immunotherapy: A Phase 1b/2 Study
2天前
待确认
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China
20天前
已完结
Senna Versus Magnesium Oxide for the Treatment of Chronic Constipation: A Randomized, Placebo-Controlled Trial
2个月前
已完结
Precision nanophytomedicine: Alginate-chitosan nanogels encapsulating Olea ferruginea ethyl acetate fraction for enhanced cardiovascular protection
5个月前
已完结
Hepatic macrophage targeted siRNA lipid nanoparticles treat non-alcoholic steatohepatitis
1年前
已完结
A mesoporous polydopamine-derived nanomedicine for targeted and synergistic treatment of inflammatory bowel disease by pH-Responsive drug release and ROS scavenging
1年前
已完结
Hepatic macrophage targeted siRNA lipid nanoparticles treat non-alcoholic steatohepatitis
1年前
已完结
Polydopamine nanoparticles as a non-pharmaceutical tool in the treatment of fatty liver disease
1年前
已完结
Polydopamine-coated ferric oxide nanoparticles for R848 delivery for photothermal immunotherapy in breast cancer
1年前
已完结
皖公网安备34019202002308
